These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25074635)

  • 1. A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part I: vaccinations.
    Wylie CE; Carbonell-Antoñanzas M; Aiassa E; Dhollander S; Zagmutt FJ; Brodbelt DC; Solano-Gallego L
    Prev Vet Med; 2014 Nov; 117(1):7-18. PubMed ID: 25074635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the efficacy of prophylactic control measures for naturally occurring canine leishmaniosis. Part II: topically applied insecticide treatments and prophylactic medications.
    Wylie CE; Carbonell-Antoñanzas M; Aiassa E; Dhollander S; Zagmutt FJ; Brodbelt DC; Solano-Gallego L
    Prev Vet Med; 2014 Nov; 117(1):19-27. PubMed ID: 25062787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend® against canine leishmaniosis.
    Fernández Cotrina J; Iniesta V; Monroy I; Baz V; Hugnet C; Marañon F; Fabra M; Gómez-Nieto LC; Alonso C
    Vaccine; 2018 Apr; 36(15):1972-1982. PubMed ID: 29525281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Challenges in the Era of Canine Leishmania infantum Vaccines.
    Solano-Gallego L; Cardoso L; Pennisi MG; Petersen C; Bourdeau P; Oliva G; Miró G; Ferrer L; Baneth G
    Trends Parasitol; 2017 Sep; 33(9):706-717. PubMed ID: 28689776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest trends in L. infantum infection in dogs in Spain, Part II: current clinical management and control according to a national survey of veterinary practitioners.
    Montoya A; Gálvez R; Checa R; Sarquis J; Plaza A; Barrera JP; Marino V; Miró G
    Parasit Vectors; 2020 Apr; 13(1):205. PubMed ID: 32317018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of canine leishmaniosis vaccine CaniLeish® under field conditions in native dog populations from an endemic Mediterranean area-A randomized controlled trial.
    Velez R; Domenech E; Rodríguez-Cortés A; Barrios D; Tebar S; Fernández-Arévalo A; Aguilar R; Dobaño C; Alberola J; Cairó J; Gállego M
    Acta Trop; 2020 May; 205():105387. PubMed ID: 32035053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of canine leishmaniosis vaccination with Canileish® in Leishmania infantum infection seroprevalence studies.
    Velez R; Domenech E; Cairó J; Gállego M
    Acta Trop; 2020 Feb; 202():105259. PubMed ID: 31703952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy.
    Velez R; Gállego M
    Trop Med Int Health; 2020 May; 25(5):540-557. PubMed ID: 32034985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of Leishmania infantum in Europe with dog travelling.
    Maia C; Cardoso L
    Vet Parasitol; 2015 Sep; 213(1-2):2-11. PubMed ID: 26021526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union.
    Calzetta L; Pistocchini E; Ritondo BL; Roncada P; Palma E; di Cave D; Mattei M; Britti D
    Vaccine; 2020 Oct; 38(43):6695-6703. PubMed ID: 32883556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with LetiFend® reduces circulating immune complexes in dogs experimentally infected with L. infantum.
    Cacheiro-Llaguno C; Parody N; Renshaw-Calderón A; Osuna C; Alonso C; Carnés J
    Vaccine; 2020 Jan; 38(4):890-896. PubMed ID: 31706810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of comorbidities in dogs with leishmaniosis due to Leishmania infantum.
    Apostolidis KN; Chatzis MK; Kasabalis D; Mataragka A; Ikonomopoulos J; Skampardonis V; Athanasiou LV; Mylonakis ME; Leontides LS; Saridomichelakis MN
    Vet Parasitol Reg Stud Reports; 2023 Apr; 39():100844. PubMed ID: 36878629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Areas for Prevention and Control of Canine Leishmaniosis.
    Miró G; Petersen C; Cardoso L; Bourdeau P; Baneth G; Solano-Gallego L; Pennisi MG; Ferrer L; Oliva G
    Trends Parasitol; 2017 Sep; 33(9):718-730. PubMed ID: 28601528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    Grimaldi G; Teva A; Dos-Santos CB; Santos FN; Pinto ID; Fux B; Leite GR; Falqueto A
    PLoS One; 2017; 12(9):e0185438. PubMed ID: 28953944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of insecticide-impregnated dog collars in reducing incidence rate of canine visceral leishmaniasis: A systematic review and meta-analysis.
    Yimam Y; Mohebali M
    PLoS One; 2020; 15(9):e0238601. PubMed ID: 32881961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
    Papadogiannakis EI; Koutinas AF
    Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on adaptive and innate immunity in canine leishmaniosis.
    Hosein S; Blake DP; Solano-Gallego L
    Parasitology; 2017 Jan; 144(1):95-115. PubMed ID: 27094260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic progression of canine leishmaniosis following vertical transmission in United States dogs.
    Vida B; Toepp A; Schaut RG; Esch KJ; Juelsgaard R; Shimak RM; Petersen CA
    Vet Immunol Immunopathol; 2016 Jan; 169():34-8. PubMed ID: 26827836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.